Skip to main content
Home

Language & Country Selector for Desktop

language-selector-globe Ireland | en

Choose Location

  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | fr
Canada | en
Central America | es
Colombia | es
Mexico | es
United States | en
Venezuela | vs
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | nl
Belgium | fr
Bulgaria | bg
Czech Republic | en
Czech Republic | cs
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | fr
Switzerland | de
United Kingdom | en
Global | en
Novartis Foundation | en
Sandoz | en
Egypt | en
Israel | he
South Africa | en
Turkey | tr

Language & Country Selector for Mobile

language-selector-globe Ireland

Choose Location

Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | nl
Belgium | fr
Brazil | pt
Bulgaria | bg
Canada | fr
Canada | en
Central America | es
Colombia | es
Czech Republic | en
Czech Republic | cs
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Global | en
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Novartis Foundation | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Sandoz | en
Serbia | sr
Singapore | en
Slovakia | sk
South Africa | en
Spain | es
Sweden | sv
Switzerland | fr
Switzerland | de
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
Venezuela | vs
    • About 
      • Novartis in Ireland 
      • Strategy 
      • Country Leadership Team 
      • Contact 
      Novartis office About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Education and Awareness 
      • Patient Resources 
      • Adverse Event Reporting 
      • Novartis Societal Impact 
      Novartis works with the patient community around the world to discover new ways to improve Patients and Caregivers
    • Healthcare Professionals 
      • Healthcare professional country resource 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Novartis works closely with healthcare professionals around the work to support their treatment of patients and collaborate on unmet needs. Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Environmental Sustainability 
      As a global company, Novartis has a great responsibility and an even greater opportunity to lead the world in creating a positive social change, embracing societal impact as a core business objective. ESG
    • News 
      • News Archive 
      • Stories 
      • Contacts 
      news landingpage_0 News
    • Careers 
      • Career Search 
      • Working in Novartis Ireland 
      • Learning and Development 
      • Early Talent 
      • How We Work 
      • Well-being 
      • Diversity & Inclusion 
      • Awards and Recognition 
      Careers 769 million lives touched by our products Careers
    • Coronavirus 
      covid 10 grey image_0_0 Coronavirus
    Scientist working at Novartis Home
  1. Home
  2. News
  3. News Archive
News Archive Navigation
  • All
  • Featured News
  • In the News
  • Stories
icon
Showing 82 results

March 2023

  • Image of Novartis staff raising a toastie to support rare disease day
    StoryMar 23, 2023
    Raise a toastie
  • Transition year students at Novartis Ireland
    StoryMar 23, 2023 People and Culture
    Novartis Ireland welcomes 25 transition year students

October 2022

  • Rosie McCormack's painting at the art of MS
    StoryOct 28, 2022 Education Awareness
    The Art of MS - Symptoms Under the Spotlight exhibition
  • photo of people at the launch of the #invisible nation campaign
    StoryOct 28, 2022 Education Awareness
    #InvisibleNation campaign launch
  • photo of attendees at the societial cost of ms report
    StoryOct 28, 2022 Education Awareness
    Launch of the Societal Cost of MS
  • psoriasis and beyond survey logo
    StoryOct 25, 2022 Education Awareness
    144 people in Ireland take part in Psoriasis and Beyond global survey

August 2022

  • Group photo of people at heart of our city launch
    StoryAug 11, 2022 Education Awareness
    Heart of Our City initiative improves health for D8 residents

April 2022

  • Featured NewsApr 22, 2022
    Novartis to handover lab facilities in Ireland to SGS
  • HealthBeacon launch Green Labs facility in Dublin
    Featured NewsApr 22, 2022
    HealthBeacon launch Green Labs facility in Dublin
  • Featured NewsApr 22, 2022
    Novartis to transfer Novartis Ringaskiddy in Ireland to Sterling Pharma Solutions
  • Featured NewsApr 22, 2022
    Heart of our City initiative launched to improve Heart Health

January 2022

  • Audrey Derveloy_0
    Featured NewsJan 11, 2022
    Novartis Country President shares outlook for 2022 – “Digital healthcare’s moment”

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • › Next page

Novartis Ireland

Navigate Novartis
  • Patients and Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • News Archive
  • Stories
Other Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2023 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
Site intended for audiences in Ireland IE208268 May 22